Figures computed from official regulatory filings — methodology.
Filing timeline · open-market
11 buys0 sellsDec 18, 2025 — Dec 30, 2025tick height = trade size
| Insider | Type | Value · USD | |
|---|---|---|---|
| GENMAB A/S | Buy | $102.1M | SEC |
| GENMAB A/S | Buy | $7.4B | SEC |
| GENMAB A/S | Buy | $288.9K | SEC |
| GENMAB A/S |
| Buy |
| $13.8M |
| SEC |
| GENMAB A/S | Buy | $9.3M | SEC |
| GENMAB A/S | Buy | $54.4M | SEC |
| GENMAB A/S | Buy | $1.5M | SEC |
| GENMAB A/S | Buy | $20.6M | SEC |
| GENMAB A/S | Buy | $6.4M | SEC |
| GENMAB A/S | Buy | $11.7M | SEC |
| GENMAB A/S | Buy | $14.6M | SEC |
| Lundberg Sven Ante | Other | $891.6K | SEC |
| Iwicki Mark T | OtherD | $0 | SEC |
| Lundberg Sven Ante | OtherD | $0 | SEC |
| Lundberg Sven Ante | Other | $891.5K | SEC |
| Silverman Peter B. | OtherD | $0 | SEC |
| Shuman Harry | OtherD | $0 | SEC |
| PERRY GREGORY D | OtherD | $0 | SEC |
| Kanavy Len | OtherD | $0 | SEC |
| Kanavy Len | OtherD | $0 | SEC |
| Lundberg Sven Ante | OtherD | $0 | SEC |
| Lundberg Sven Ante | OtherD | $0 | SEC |
| Silverman Peter B. | OtherD | $0 | SEC |
| Iwicki Mark T | OtherD | $0 | SEC |
| Iwicki Mark T | OtherD | $0 | SEC |